Back to results
US 2022/0177483 A1Published application
Crystal form of acid addition salt of furopyrimidine compound
AssigneeHanmi Pharm. Co., Ltd.
InventorsHee Sook OH, Jae Hyuk JUNG, Ji Young JEON, Sun Young JANG, Tae Hee HA
Life of this patent
Estimating the term…
Abstract
Provided are crystalline forms of acid addition salts of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)furo[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide, and a pharmaceutical composition including the same. The crystalline forms may be easily used in preparing the pharmaceutical composition including the same as an active ingredient.
Claims19
A crystalline form of an acid addition salt of the following compound of Formula 1:
A pharmaceutical composition comprising a crystalline form of an acid addition salt of the following compound of Formula 1:
- and one or more pharmaceutically acceptable carriers or diluents.
Dependencies are inferred from the claim text.